Published in Rev Laryngol Otol Rhinol (Bord) on January 01, 1992
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med (1998) 4.93
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29
Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N Engl J Med (1999) 2.14
Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol (2009) 2.12
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. Ann Oncol (2002) 2.03
Taxane-induced glaucoma. Lancet (1999) 2.02
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol (2000) 1.57
Adjuvant therapy by BCG of non-Hodgkin's malignant lymphomas in a controlled trial: an update. Br J Haematol (1989) 1.39
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology (2001) 1.37
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med (2001) 1.20
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol (2008) 1.18
Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group. J Clin Oncol (1999) 1.14
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. Ann Oncol (2012) 1.12
Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer. Ann Oncol (2009) 1.03
Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut (1990) 1.02
Primary intraosseous carcinoma of the jaws. Arch Otolaryngol Head Neck Surg (2001) 0.99
Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports. Ann Oncol (2009) 0.97
A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy. Blood (1998) 0.97
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape. J Clin Oncol (1999) 0.94
Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol (2014) 0.90
Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg (2000) 0.90
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. Eur J Cancer (2005) 0.90
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis. Br J Cancer (2012) 0.87
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer. Ann Oncol (2007) 0.86
Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases. Eur J Cancer (1996) 0.85
[Fractures of the upper tibia and thromboembolic risk]. Agressologie (1976) 0.85
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer. Eur J Cancer (2003) 0.85
Biological disturbances during drowning in sea water. Resuscitation (1974) 0.85
Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment--the experience of one institute. Am J Clin Oncol (2001) 0.83
[The horizontal infrahyoid myocutaneous flap: surgical technique]. Rev Stomatol Chir Maxillofac (2008) 0.82
PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation. Oncology (2006) 0.81
Supraomohyoid neck dissection in cancer of the oral cavity. Am J Surg (1999) 0.80
Impairment of monocyte functions in advanced head and neck cancer. Immunol Lett (1988) 0.80
Fine-needle aspiration diagnosis of hydatid cyst. P R Health Sci J (1999) 0.80
Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma. Oncology (2011) 0.80
[Adverse effects of interleukin 2]. Bull Cancer (1991) 0.79
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology. Eur J Cancer (2012) 0.79
Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol (2014) 0.78
Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes. Eur J Cancer (1992) 0.78
Colonic metastasis of a renal carcinoma. A case report. Tumori (1992) 0.78
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology (2001) 0.78
Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial. Eur J Cancer Clin Oncol (1986) 0.78
[Study of bioavailability parameters of propranolol in cirrhotic patients after oral administration of the delayed-action form]. Therapie (1987) 0.78
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment. Clin Res Hepatol Gastroenterol (2011) 0.77
[Systemic chemotherapy in metastatic colorectal adenocarcinomas]. Gastroenterol Clin Biol (1992) 0.77
[Targeted therapy for locally advanced and/or metastatic bladder cancer]. Prog Urol (2008) 0.77
In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates. Int J Cancer (2000) 0.77
Word priming with brief multiple presentation technique: preservation in amnesia. Neuropsychologia (1997) 0.76
Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients. Eur Radiol (2013) 0.76
Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension. Br J Clin Pharmacol (1989) 0.76
[Does surgery promote the development of metastasis in melanoma?]. Ann Chir Plast Esthet (2000) 0.76
[Hand-foot syndrome and sorafenib]. Bull Cancer (2009) 0.76
[Randomized trial with tiapride in post-operative care (author's transl)]. Ann Chir (1981) 0.76
VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma. Ann Oncol (2009) 0.76
[Bleaching of vital teeth. Part one of a comparative study of two ambulatory methods]. Inf Dent (1991) 0.76
[A comprehensive diagnostic and therapeutic approach to cervical lymph node metastasis from unknown primary site (author's transl)]. Ann Otolaryngol Chir Cervicofac (1981) 0.75
[Results of 10 years of a randomized trial of neoadjuvant chemotherapy in breast cancers larger than 3 cm]. Chirurgie (1998) 0.75
Gastric lipase in alcoholic pancreatitis. Comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency. Gastroenterology (1990) 0.75
[The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies]. Prog Urol (2008) 0.75
[Anterior esthetic restorations with bonded veneers in composite resins: an original technic]. Cah Prothese (1986) 0.75
[Nutritional support in patients with oral and pharyngeal carcinomas (author's transl)]. Ann Chir (1981) 0.75
Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol (1998) 0.75
[What is the clinical practice of partial nephrectomy in France?]. Prog Urol (2008) 0.75
[Use of pectoralis major cutaneomuscular flaps in cervicofacial reconstruction. Apropos of 22 cases]. Ann Chir Plast (1982) 0.75
[Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases]. Rev Fr Gynecol Obstet (1990) 0.75
[Conservative axillary curettage in the treatment of operable breast cancers]. J Chir (Paris) (1987) 0.75
[Cancer of the oral cavity without palpable adenopathy: value of external irradiation exclusively]. Ann Otolaryngol Chir Cervicofac (1985) 0.75
[Controlled trial and cost/efficacy evaluation of the prevention of infectious complications in surgery of cancers of the upper aerodigestive tract with peri-operative cefoxitin]. Ann Otolaryngol Chir Cervicofac (1985) 0.75
Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma. J Immunother (1998) 0.75
[Renal cell carcinoma: the end of a tunnel?]. Pathol Biol (Paris) (2006) 0.75
Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- or second-line treatment in advanced malignant melanoma: a trial of the EORTC Clinical Studies Group. Melanoma Res (1999) 0.75
A survey in general practice about undergraduate cancer education: results from Gironde (France). J Cancer Educ (1991) 0.75
In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer. Hematol Cell Ther (1997) 0.75
[Spectrophotometric determination of Congo red in the serum]. Ann Biol Clin (Paris) (1970) 0.75
IORT: a randomized trial in primary rectal cancer by the French group of IORT. Front Radiat Ther Oncol (1997) 0.75
Cutaneous versus myocutaneous flaps in the repair of major defects in head and neck cancer: a study of 331 flaps. Head Neck Surg (1984) 0.75
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction. Invest New Drugs (2012) 0.75
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours. Cancer Chemother Pharmacol (2013) 0.75
[Our experience with a delto-pectoral flap in cervicofacial oncology. Apropos of a series of 123 cases]. Ann Chir Plast (1980) 0.75
The incidence of cancer in contralateral reduction mammaplasty after mastectomy and reconstruction of the removed breast. Tumori (1986) 0.75
[Squamous-cell carcinoma of the uvula and the soft palate. Analysis of a series of 71 cases seen at the Fondation Bergonié from 1971 to 1978 (author's transl)]. Ann Otolaryngol Chir Cervicofac (1981) 0.75
[Use of cutaneous and myocutaneous flaps in cervicofacial oncology. Retrospective analysis of 230 cases]. Ann Chir Plast Esthet (1983) 0.75
[Approach to therapeutic risk by study of operative mortality. From 102 postoperative deaths between 1975 and 1984 at the Fondation Bergonié]. J Chir (Paris) (1987) 0.75
[Immediate repair of urethroperineal fistulas after abdominoperineal amputation by means of a cutaneo-muscular flap of the gluteus maximus. Apropos of 2 successfully treated cases]. J Chir (Paris) (1986) 0.75
[Extramammary carcinoid tumor metastatic to the breast. Apropos of a case]. Bull Cancer (1992) 0.75
[Role of adjuvant chemotherapy in the treatment of soft tissue sarcoma]. Bull Cancer (1997) 0.75
[Role of radiotherapy in cancer of the ethmoid. Retrospective study of a series of 24 cases]. Ann Radiol (Paris) (1991) 0.75
[Radiofrequency ablation in the treatment of liver and lung tumors]. Bull Cancer (2009) 0.75
[Radiotherapy of carcinoma of the nasopharynx]. Ann Otolaryngol Chir Cervicofac (1990) 0.75
[Diffuse chronic desquamative gingivitis. Clinical, anatomopathological and biological aspects. V. Evaluation of biological studies]. Rev Stomatol Chir Maxillofac (1971) 0.75
[Prognostic significance of isolated local recurrences in breast cancer following mastectomy and axillary node excision. Apropos of 77 recurrences in 2362 patients]. Bull Cancer (1986) 0.75
[Bladder cancer and new drugs]. Bull Cancer (2010) 0.75
Ethmoidal cancers: a retrospective study of 22 cases. Int J Radiat Oncol Biol Phys (1993) 0.75
[Management of muscle invasive bladder in elderly]. Prog Urol (2010) 0.75
[Apropos of the standards, options and recommendations for the management of primary adenocarcinoma of the rectum. Conversation with Y. Bècouarn]. Presse Med (1999) 0.75